Strategies to increase nitric oxide signalling in cardiovascular disease

JO Lundberg, MT Gladwin, E Weitzberg - Nature reviews Drug …, 2015 - nature.com
Nitric oxide (NO) is a key signalling molecule in the cardiovascular, immune and central
nervous systems, and crucial steps in the regulation of NO bioavailability in health and …

[HTML][HTML] Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers

JA Borovac, D D'Amario, J Bozic… - World journal of …, 2020 - ncbi.nlm.nih.gov
Heart failure (HF) is a complex clinical syndrome characterized by the activation of at least
several neurohumoral pathways that have a common role in maintaining cardiac output and …

Cancer therapy–induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies

VS Hahn, DJ Lenihan, B Ky - Journal of the American Heart …, 2014 - Am Heart Assoc
The patient is a 63-year-old man with a history of wellcontrolled hypertension who is
diagnosed with diffuse large B-cell lymphoma and treated with a doxorubicincontaining …

Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases

SA Omar, AJ Webb, JO Lundberg… - Journal of internal …, 2016 - Wiley Online Library
Nitric oxide (NO) is generated endogenously by NO synthases to regulate a number of
physiological processes including cardiovascular and metabolic functions. A decrease in the …

Nebivolol: the somewhat-different β-adrenergic receptor blocker

T Münzel, T Gori - Journal of the American College of Cardiology, 2009 - jacc.org
Although its clinical use in Europe dates almost 10 years, nebivolol is a β-blocker that has
been only recently introduced in the US market. Like carvedilol, nebivolol belongs to the …

Alterations in endothelial nitric oxide synthase activity and their relevance to blood pressure

T Suvorava, S Metry, S Pick, G Kojda - Biochemical pharmacology, 2022 - Elsevier
Among all physiologic functions of nitric oxide (NO) known so far, NO-dependent regulation
of vascular tone is one of the most important. Under physiological conditions vascular NO is …

Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase

C Belge, J Hammond, E Dubois-Deruy, B Manoury… - Circulation, 2014 - Am Heart Assoc
Background—β1-2-adrenergic receptors (AR) are key regulators of cardiac contractility and
remodeling in response to catecholamines. β3-AR expression is enhanced in diseased …

[HTML][HTML] The effects of microgravity and space radiation on cardiovascular health: From low-Earth orbit and beyond

S Patel - IJC Heart & Vasculature, 2020 - Elsevier
The unique conditions of space harbor considerable challenges for astronauts to overcome.
Namely, the ionizing content of space radiation and the effects of microgravity have been …

β3-Adrenoceptors in the cardiovascular system: putative roles in human pathologies

B Rozec, C Gauthier - Pharmacology & therapeutics, 2006 - Elsevier
The sympathetic nervous system is central for the neurohumoral regulation of the
cardiovascular system and is largely involved in many cardiovascular diseases affecting …

Targeting nitric oxide with natural derived compounds as a therapeutic strategy in vascular diseases

M Forte, V Conti, A Damato, M Ambrosio… - Oxidative medicine …, 2016 - Wiley Online Library
Within the family of endogenous gasotransmitters, nitric oxide (NO) is the smallest gaseous
intercellular messenger involved in the modulation of several processes, such as blood flow …